title: The value of PET ligand discovery to CNS drug development.
authors.affiliation: Neuroscience Therapeutic Area, Janssen Research & Development, Division of Janssen Pharmaceutica, NV, Turnhoutseweg 30, Beerse 2340, Belgium.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Schmidt
authors.affiliation: Discovery Sciences, Janssen Research & Development, Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain.
authors.forename: José Ignacio
authors.initials: JI
authors.lastname: Andrés
mesh_terms: D002491:Central Nervous System Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002493:Central Nervous System Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D055808:Drug Discovery; D006801:Humans; D008024:Ligands; D049268:Positron-Emission Tomography
chemical_list: D002491:Central Nervous System Agents; D008024:Ligands
keywords: Alzheimer's disease; CNS drug development; PET; positron emission tomography